We're Interested To See How Celldex Therapeutics (NASDAQ:CLDX) Uses Its Cash Hoard To Grow

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com

Simply Wall StMay 8 22:01

Celldex Therapeutics: A Strong Buy on Impressive Barzolvolimab Results and Promising Pipeline

TipRanksMay 8 11:56

Celldex Therapeutics | 10-Q: Quarterly report

Futu NewsMay 7 04:13 · Announcements

Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000

04:05 PM EDT, 05/06/2024 (MT Newswires) -- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000

MT NewswiresMay 7 04:05

Celldex Therapeutics Q1 EPS $(0.56) Beats $(0.69) Estimate, Sales $156.00K Miss $920.00K Estimate

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.69) by 18.84 percent. This is a 9.68 percent increase over losses of

BenzingaMay 7 04:04

Celldex Therapeutics: Cash, Cash Equivalents and Marketable Securities at March 31 Sufficient to Meet Estimated Working Cap Requirements and Fund Current Planned Ops Through 2027 >CLDX

Celldex Therapeutics: Cash, Cash Equivalents and Marketable Securities at March 31 Sufficient to Meet Estimated Working Cap Requirements and Fund Current Planned Ops Through 2027 >CLDX

Dow JonesMay 7 04:02